106 related articles for article (PubMed ID: 32914211)
21. Nuclear factor-κB regulates the expression of multiple genes encoding liver transport proteins.
Balasubramaniyan N; Ananthanarayanan M; Suchy FJ
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(8):G618-28. PubMed ID: 26867564
[TBL] [Abstract][Full Text] [Related]
22. Zeta-crystallin mediates the acid pH-induced increase of BSC1 cotransporter mRNA stability.
Szutkowska M; Vernimmen C; Debaix H; Devuyst O; Friedlander G; Karim Z
Kidney Int; 2009 Oct; 76(7):730-8. PubMed ID: 19657324
[TBL] [Abstract][Full Text] [Related]
23. Farnesoid X receptor regulates SULT1E1 expression through inhibition of PGC1α binding to HNF4α.
Wang S; Yuan X; Lu D; Guo L; Wu B
Biochem Pharmacol; 2017 Dec; 145():202-209. PubMed ID: 28912067
[TBL] [Abstract][Full Text] [Related]
24. LXR alpha transactivates mouse organic solute transporter alpha and beta via IR-1 elements shared with FXR.
Okuwaki M; Takada T; Iwayanagi Y; Koh S; Kariya Y; Fujii H; Suzuki H
Pharm Res; 2007 Feb; 24(2):390-8. PubMed ID: 17177110
[TBL] [Abstract][Full Text] [Related]
25. Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter.
Renga B; Migliorati M; Mencarelli A; Cipriani S; D'Amore C; Distrutti E; Fiorucci S
Biochim Biophys Acta; 2011 Mar; 1809(3):157-65. PubMed ID: 21296199
[TBL] [Abstract][Full Text] [Related]
26. Natural structural variants of the nuclear receptor farnesoid X receptor affect transcriptional activation.
Zhang Y; Kast-Woelbern HR; Edwards PA
J Biol Chem; 2003 Jan; 278(1):104-10. PubMed ID: 12393883
[TBL] [Abstract][Full Text] [Related]
27. Farnesoid X receptor activation by chenodeoxycholic acid induces detoxifying enzymes through AMP-activated protein kinase and extracellular signal-regulated kinase 1/2-mediated phosphorylation of CCAAT/enhancer binding protein β.
Noh K; Kim YM; Kim YW; Kim SG
Drug Metab Dispos; 2011 Aug; 39(8):1451-9. PubMed ID: 21596890
[TBL] [Abstract][Full Text] [Related]
28. [Development and optimization of a cell screening system for farnesoid X receptor agonist].
Zheng Z; Huang X; Pang B; Huang N; Kong B; Li X; Xiong W
Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):359-371. PubMed ID: 36738222
[TBL] [Abstract][Full Text] [Related]
29. Farnesoid X receptor represses matrix metalloproteinase 7 expression, revealing this regulatory axis as a promising therapeutic target in colon cancer.
Peng Z; Chen J; Drachenberg CB; Raufman JP; Xie G
J Biol Chem; 2019 May; 294(21):8529-8542. PubMed ID: 30967475
[TBL] [Abstract][Full Text] [Related]
30. Hematopoietically expressed homeobox is a target gene of farnesoid X receptor in chenodeoxycholic acid-induced liver hypertrophy.
Xing X; Burgermeister E; Geisler F; Einwächter H; Fan L; Hiber M; Rauser S; Walch A; Röcken C; Ebeling M; Wright MB; Schmid RM; Ebert MP
Hepatology; 2009 Mar; 49(3):979-88. PubMed ID: 19072826
[TBL] [Abstract][Full Text] [Related]
31. Activation of FXR pathway does not alter glial cell function.
Albrecht S; Fleck AK; Kirchberg I; Hucke S; Liebmann M; Klotz L; Kuhlmann T
J Neuroinflammation; 2017 Mar; 14(1):66. PubMed ID: 28351411
[TBL] [Abstract][Full Text] [Related]
32. Tonicity-responsive enhancer binding protein is an essential regulator of aquaporin-2 expression in renal collecting duct principal cells.
Hasler U; Jeon US; Kim JA; Mordasini D; Kwon HM; Féraille E; Martin PY
J Am Soc Nephrol; 2006 Jun; 17(6):1521-31. PubMed ID: 16641150
[TBL] [Abstract][Full Text] [Related]
33. Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL.
Mutig K; Paliege A; Kahl T; Jöns T; Müller-Esterl W; Bachmann S
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1166-77. PubMed ID: 17626156
[TBL] [Abstract][Full Text] [Related]
34. Renal Farnesoid X Receptor improves high fructose-induced salt-sensitive hypertension in mice by inhibiting DNM3 to promote nitro oxide production.
Zhu Y; Tao Y; Wu C; Zeng Y; Du H; Xiang Q; Chen Y; Zhu Q; Wang L
J Hypertens; 2022 Aug; 40(8):1577-1588. PubMed ID: 35792095
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of thrombomodulin expression by activation of farnesoid X receptor in vascular endothelial cells.
He X; Xu Z; Wang B; Zheng Y; Gong W; Huang G; Zhang L; Li Y; He F
Eur J Pharmacol; 2013 Oct; 718(1-3):283-9. PubMed ID: 24041925
[TBL] [Abstract][Full Text] [Related]
36. Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver.
Zollner G; Wagner M; Fickert P; Geier A; Fuchsbichler A; Silbert D; Gumhold J; Zatloukal K; Kaser A; Tilg H; Denk H; Trauner M
Am J Physiol Gastrointest Liver Physiol; 2005 Nov; 289(5):G798-805. PubMed ID: 16002565
[TBL] [Abstract][Full Text] [Related]
37. Src-mediated crosstalk between FXR and YAP protects against renal fibrosis.
Kim DH; Choi HI; Park JS; Kim CS; Bae EH; Ma SK; Kim SW
FASEB J; 2019 Oct; 33(10):11109-11122. PubMed ID: 31298930
[TBL] [Abstract][Full Text] [Related]
38. The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes.
Murakami T; Walczak R; Caron S; Duhem C; Vidal V; Darteil R; Staels B
Biochem J; 2007 Nov; 407(3):461-9. PubMed ID: 17655523
[TBL] [Abstract][Full Text] [Related]
39. FXR regulates organic solute transporters alpha and beta in the adrenal gland, kidney, and intestine.
Lee H; Zhang Y; Lee FY; Nelson SF; Gonzalez FJ; Edwards PA
J Lipid Res; 2006 Jan; 47(1):201-14. PubMed ID: 16251721
[TBL] [Abstract][Full Text] [Related]
40. Disruption of prostaglandin E2 receptor EP4 impairs urinary concentration via decreasing aquaporin 2 in renal collecting ducts.
Gao M; Cao R; Du S; Jia X; Zheng S; Huang S; Han Q; Liu J; Zhang X; Miao Y; Kang J; Gustafsson JÅ; Guan Y
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8397-402. PubMed ID: 26100911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
